{"id":"https://openalex.org/A5116866391","orcid":"https://orcid.org/0009-0006-2292-2868","observed_orcids":["https://orcid.org/0009-0006-2292-2868"],"display_name":"Sara Emarloo","raw_author_names":["Sara Emarloo"],"full_name":"Sara Emarloo","works_count":3,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5116866391","orcid":"https://orcid.org/0009-0006-2292-2868","observed_orcids":["https://orcid.org/0009-0006-2292-2868"]},"affiliations":[{"institution":{"id":"https://openalex.org/I165560825","ror":"https://ror.org/04sfka033","display_name":"Mashhad University of Medical Sciences","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I165560825","ror":"https://ror.org/04sfka033","display_name":"Mashhad University of Medical Sciences","country_code":"IR","type":"education","lineage":["https://openalex.org/I165560825"]}],"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","count":1,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","count":1,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11000","display_name":"Infection Control in Healthcare","count":1,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","value":7.1e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","value":4.4e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11452","display_name":"Oral Health Pathology and Treatment","value":4e-06,"subfield":{"id":"https://openalex.org/subfields/3500","display_name":"General Dentistry"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","value":3.1e-06,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","value":2.7e-06,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8752999901771545},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.48500001430511475},{"id":"107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","score":0.35120001435279846},{"id":"146304588","wikidata":"https://www.wikidata.org/wiki/Q961652","display_name":"Case-control study","score":0.2822999954223633},{"id":"138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","score":0.2741999924182892}],"counts_by_year":[{"year":2025,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":2}],"display_name_alternatives":["Sara Emarloo"],"block_key":"s emarloo","works_api_url":"https://api.openalex.org/works?filter=author.id:A5116866391","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5116866391","updated_date":"2026-11-16T12:53:42","created_date":"2025-04-01T00:00:00"}
